Skip to main content

Table 1 Antibacterial activity of Fe/Cu/P nanocomposite. Data represent the diameter of the inhibition zone (in mm) that is formed as a result of Fe/Cu/P nanocomposite application at 100 and 300 ppm concentration in comparison to positive control (Ciprofloxacin, 5 µg) and negative control (dis. H2O). Means with different letters are significantly different

From: Iron/Copper/Phosphate nanocomposite as antimicrobial, antisnail, and wheat growth-promoting agent

Treatment

Inhibition zone diameter (mm)

E. coli ATCC 7839

E. coli ATCC 25922

S. typhi ATCC 6539

S. enterica ATCC 25566

Fe/Cu/P nanocomposite (100 ppm)

13.75 ± 0.18C

0.0 ± 0.0B

0.0 ± 0.0C

0.0 ± 0.0

Fe/Cu/P nanocomposite (300 ppm)

20.25 ± 0.18B

0.0 ± 0.0B

22.0 ± 1.4B

0.0 ± 0.0

Ciprofloxacin (5 µg)

32.75 ± 0.53A

40.5 ± 0.35A

34.0 ± 0.0A

0.0 ± 0.0

Negative control (dis. H2O)

0.0 ± 0.0D

0.0 ± 0.0B

0.0 ± 0.0C

0.0 ± 0.0

  1. The highest inhibition was exerted by ciprofloxacin (A), followed by 300 ppm nanocomposite (B) and 100 ppm nanocomposite concentrations (C, D), respectively